| Literature DB >> 32993726 |
Hongtao Tie1, Lingwen Kong2, Zhengjie Tu1, Dan Chen1, Delai Zheng1, Qingchen Wu1, Qiang Li3.
Abstract
BACKGROUND: Open stented elephant trunk (SET) or SET with left subclavian artery (LSCA) to left common carotid artery (LCCA) bypass is proven to a potentially alternative treatment for complicated Stanford type B aortic dissection (TBAD). In the current study, we reported our experience with ten consecutive TBAD patients who underwent open SET.Entities:
Keywords: Complicated Stanford type B aortic dissection; Stented elephant trunk; Subclavian artery correction
Mesh:
Year: 2020 PMID: 32993726 PMCID: PMC7526183 DOI: 10.1186/s13019-020-01341-6
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Fig. 1Schematic illustration of the surgery and patients’ postoperative CT. a Intimal tear near to the origin of the left subclavian artery; b Schematic illustration of SET with LSCA-LCCA bypass; c, d postoperative CT of patietns after surgery
Patients baseline characteristics
| Variables | n(%)/Mean(R) |
|---|---|
| Gender (Male) | 9 (90%) |
| Age (years) | 47.3 (31–65) |
| Height (cm) | 166.6 (140–177) |
| Weight (kg) | 73 (46–90) |
| BMI (Kg/m2) | 26.1 (21.3–31.1) |
| Heart beat at admission (bpm) | 89.8 (63–105) |
| Systolic blood pressure at admission (mmHg) | 161.2 (117–224) |
| Diastolic blood pressure at admission (mmHg) | 97.7 (77–142) |
| Hypertension | 10 (100%) |
| diabetes mellitus | 0 |
| Coronary artery disease | 1 (10%) |
| current smoker | 8 (80%) |
| Drink | 6 (60%) |
| Platelet count at admission (X10^9) | 244.1 (94–403) |
| D dimer (mg/L FEU) | 3.8 (1.5–13.1) |
| FDP (ug/ml) | 11.3 (3.8–33.5) |
| Serum creatinine (umol/L) | 92.9 (47–208) |
| Mild ascending aorta dilatation | 2 (20%) |
| Right subclavian artery vagus | 2 (20%) |
| Lesions involving left subclavian artery | 4 (40%) |
| Lesions involving renal artery | 3 (30%) |
| Left ventricular hypertrophy, | 7 (70%) |
| Dissection aneurysm with thrombus | 1 (10%) |
BMI Body Mass Index, FDP fibrinogen degradation product
Intraoperative variables
| Variables | Mean (R) |
|---|---|
| CPB duration (mins) | 139.1 (121–169) |
| Aortic cross clamp (mins) | 68.7 (43–100) |
| Mean cerebral perfusion time (mins) | 42.0 (32–55) |
| RBC transfusion (U) | 340 (0–400) |
| Plasma transfusion (ml) | 490 (0–800) |
| Platelet transfusion (U) | 2.2 (0–3) |
| Cryoprecipitate transfusion (U) | 1 (0–6) |
| Urine volume (ml) | 575 (40–1000) |
CPB cardiopulmonary bypass, RBC red blood cell
Early postoperative complications
| Variable | n (%) |
|---|---|
| Myocardial injury | 1 (10%) |
| Atrial fibrillation | 1 (10%) |
| Ventricular fibrillation | 1 (10%) |
| Renal insufficiency | 1 (10%) |
| Acute kidney injury | 2 (20%) |
| Liver dysfunction | 7 (70%) |
| CRRT | 1 (10%) |
| Intratracheal intubation again | 1 (10%) |
| Mechanical ventilation time > 48 h | 3 (30%) |
| Delirium | 1 (10%) |
Renal insufficiency: serum creatinine >133umol/L; acute kidney injury: Scr>226 umol/L or CRRT; Liver dysfunction: elevated aspartate aminotransferase or alanine aminotransferase with elevated total bilirubin or direct bilirubin after surgery; Myocardial injury: cTnT> 0.2 μg/L. CRRT, continuous renal replacement therapy